ProShare Advisors LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,013
-16.4%
22,234
-0.1%
0.00%
Q2 2023$28,711
+7.1%
22,257
+9.6%
0.00%
Q1 2023$26,809
-19.5%
20,310
-8.5%
0.00%
Q4 2022$33,308
-16.7%
22,205
-33.8%
0.00%
Q3 2022$40,000
+8.1%
33,559
+2.4%
0.00%
Q2 2022$37,000
-75.2%
32,785
-34.1%
0.00%
Q1 2022$149,000
-8.6%
49,731
-19.0%
0.00%
Q4 2021$163,000
-23.1%
61,409
+5.2%
0.00%
-100.0%
Q3 2021$212,000
-34.8%
58,391
-22.0%
0.00%0.0%
Q2 2021$325,000
+38.3%
74,901
+9.0%
0.00%0.0%
Q1 2021$235,000
+5.4%
68,731
+7.9%
0.00%0.0%
Q4 2020$223,000
+93.9%
63,727
+32.6%
0.00%0.0%
Q3 2020$115,000
+25.0%
48,055
-3.9%
0.00%
Q2 2020$92,000
+80.4%
50,028
+52.0%
0.00%
Q1 2020$51,000
-59.5%
32,907
-44.3%
0.00%
-100.0%
Q4 2019$126,000
+4.1%
59,051
-8.5%
0.00%0.0%
Q3 2019$121,000
-30.5%
64,534
-3.1%
0.00%0.0%
Q2 2019$174,000
-9.8%
66,579
-11.3%
0.00%0.0%
Q1 2019$193,000
+12.9%
75,042
+1.2%
0.00%0.0%
Q4 2018$171,000
-39.8%
74,174
-16.1%
0.00%
-50.0%
Q3 2018$284,000
+10.9%
88,413
-2.3%
0.00%0.0%
Q2 2018$256,000
-16.6%
90,478
+4.4%
0.00%0.0%
Q1 2018$307,000
-21.5%
86,639
-14.1%
0.00%
-33.3%
Q4 2017$391,000
+95.5%
100,879
+28.2%
0.00%
+50.0%
Q3 2017$200,000
-0.5%
78,697
+6.7%
0.00%0.0%
Q2 2017$201,000
-23.6%
73,769
-7.2%
0.00%
-33.3%
Q1 2017$263,000
+35.6%
79,452
-2.4%
0.00%
+50.0%
Q4 2016$194,000
-23.0%
81,423
+18.5%
0.00%
-50.0%
Q3 2016$252,000
+41.6%
68,728
-14.1%
0.00%
+100.0%
Q2 2016$178,000
+12.7%
79,983
+5.5%
0.00%0.0%
Q1 2016$158,000
-38.0%
75,842
-9.7%
0.00%
-33.3%
Q4 2015$255,000
+608.3%
84,022
+655.4%
0.00%
Q2 2015$36,000
-40.0%
11,123
-34.2%
0.00%
-100.0%
Q1 2015$60,000
+42.9%
16,911
-8.2%
0.00%
Q4 2014$42,000
-72.7%
18,424
-76.9%
0.00%
-100.0%
Q3 2014$154,000
-55.5%
79,607
-16.4%
0.00%
-50.0%
Q2 2014$346,000
-42.5%
95,280
-38.6%
0.00%
-50.0%
Q1 2014$602,000
+370.3%
155,074
+244.0%
0.01%
+300.0%
Q4 2013$128,000
-58.4%
45,076
-47.6%
0.00%
-71.4%
Q3 2013$308,000
+27.8%
86,053
+19.5%
0.01%
+40.0%
Q2 2013$241,00072,0340.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders